Compounded Sermorelin, Compared on Price and Pharmacy Transparency
75 providers, each read directly off its own site — only 21 names its pharmacy and states a regulatory category; the rest don't say.
On this page▾
If you are drug-tested, every peptide on this page is banned
Not just on race day — in and out of competition, year-round, and a prescription does not make them allowed. That covers sermorelin, CJC-1295, tesamorelin, ipamorelin and the rest of the GH-releasing family. Anti-doping calls this class S2; what it means in practice is that a positive test is a violation even if a doctor prescribed it. Not tested? None of this applies to you. Check any compound against the official WADA Prohibited List first.
/ The board
Any paid placement here is marked Partner and listed first, as a disclosed commercial position — within that group, and separately within every other row, every provider is still ranked on the criteria printed on this page, never anything else (see disclosure). Full write-ups below.
“Flat price” means one all-in monthly figure with no separate membership or lab fee; any other pricing chip names the mechanic that gets in the way, or that the provider has not stated one. “Labs” is whether bloodwork is required, optional, not used, or not stated on the provider's own site. The pharmacy chip states a facility type (503A pharmacy, 503B facility, or 503A + 503B network where a company names pharmacies in both categories) only where the provider publishes one we could cite; “Not disclosed” means we read their site and they do not say, and “Unverified” means nobody has checked this company's pharmacy sourcing yet — of the 75 providers listed, 21 publish a facility type at all. Every provider here includes the clinician consult. Each row above shows the exact date its price was checked on that provider's own site — prices can change without notice. Compounded sermorelin is not an FDA-approved product, and there is no proven performance or body-composition benefit.
Every provider read live off its own site in August 2026, ranked by the same criteria as the board above: pharmacy disclosure first, then advertised price, low to high. #1 is our top pick on those criteria — filter to see the rest a different way.
Showing our top 10 of 75, by pharmacy disclosure then price
1
CoreAge Rx
The lowest advertised starting price here — with the same undisclosed-pharmacy and unpublished-ceiling caveats as its tirzepatide listing.
The $119/mo "Auto Refill" headline (and a cheaper $99/mo oral-lozenge option) are real, published prices — but neither product page discloses the one-time, non-auto-refill rate anywhere, and the company's own blog gives a discount percentage that doesn't match the badge shown on the product page itself.
Sells a genuine no-injection option — an oral sermorelin lozenge/troche, headlined at $99/mo, cheaper than the $119/mo injectable — a real alternative for a needle-averse reader, unlike a board peer that markets one and never actually sells it
Names both fulfillment pharmacies outright — F&F Pharmacies dba Jungle Jim's Pharmacy and Specialty Medical Drugstore dba GoGoMeds — where most competitors name none.
Names two specific fulfillment pharmacies directly for its GLP-1 products (F&F Pharmacies dba Jungle Jim's Pharmacy, Specialty Medical Drugstore dba GoGoMeds)
A real, flat monthly sermorelin price stated directly on its own product page, with an explicit "pause or cancel anytime" claim — but its pharmacy is described, not named.
Its own sermorelin page says "Compounded" directly — but the "From $129" figure right above it is the 12-month prepay rate; the real month-to-month price, found only in the site's own pricing-quiz data, is $199/mo.
Sells sermorelin under its own product brand, "Sermorix," at a real flat price with no subscription trap — but no pharmacy is named anywhere, and no public Terms of Service page exists on the live site.
A real, findable sermorelin price with no prepay trap — undercut by a real, sourced contradiction between its own marketing ("all 50 states") and its own Terms of Use (the state list is undisclosed; contact customer service to find out).
Sells a real Sermorelin Injection product — but the only price it publishes, "First month as low as $126," is its own asterisked 3-Month-plan promo, and no standing month-to-month rate appears anywhere on the site.
Names and links its own pharmacy, edenpharmacy.com, rather than an unnamed network — the same real, checkable acquisition (Contigo Compounding) backing its tirzepatide listing
Its full four-tier price ladder is real and the multi-month discounts are honestly calculated — each total genuinely costs less than that plan's own monthly rate over the same period
A real, disclosed "$109 first month, then $219/month" sermorelin price — a 101% jump after the introductory month — with no pharmacy name or regulatory category stated anywhere on the site.
$219/mo
What this price covers
✓
Medication
Included
✓
Provider visits
Included
Shipping
Not confirmed
–
Lab work
Not disclosed
–
Coaching
Not disclosed
The standing, post-introductory price ($219/mo) is disclosed directly in the same sentence as the introductory rate, not buried elsewhere
Names FOUR pharmacies directly on its own pharmacy partners page (Pharmacy Innovations, Sweetgrass Pharmacy & Compounding, Absolute Pharmacy, Striker Pharmacy) and states the category outright: "licensed 503A pharmacies, not 503B outsourcing facilities"
A flat, single $120/month with no plan-tier selector and no first-month teaser — names five pharmacies on a dedicated Clinical & Pharmacy Partners page, but markets "HIPAA-Compliant Care" while its own Terms & Conditions say it is not a HIPAA covered entity.
A flat, single $120/month price with no plan-tier selector, no first-month-only teaser rate, and no promo code required to see it — simpler than most rows here
Names its secondary pharmacy with a genuinely specific, sourced 10-state exclusion list — but its own "as low as $125" headline sits next to a $299 "compare" price the site never confirms is an actual 1-month rate.
The same on-page pricing structure as its semaglutide listing — both figures (the promotional "as low as" price and the higher "compare" price) shown together, not hidden behind an account or quiz
The single best-documented pharmacy disclosure here — six named pharmacies, each with its own 503(a)/503(b) category and its own state-exclusion list — but every price is an 8-week package total, never a monthly rate.
Names SIX specific pharmacies by name, each with its own stated 503(a)/503(b) category and its own state-exclusion list: Apothecary Pharma (503(b), all states), BPI Labs (503(b), all states via intermediary), OptioRx (503(a), a named sub-network, all states), Hallandale Pharmacy (503(a), excludes 6 named states), Miller's Pharmacy (503(a), excludes CA), Boudreaux's New Drug Store (503(a), excludes 4 named states)
The most literally transparent pricing table here — 1/3/6/12-month prices shown side by side, no click required — but its own "as low as" headline everywhere else on the site is the 12-month prepay figure, 27% below the real 1-month rate.
The only board entry whose pricing page shows the 1-month, 3-month, 6-month, and 12-month price together in one table, with nothing hidden behind a click or a quiz
Names its dispensing pharmacy outright — "dispensed through Strive Pharmacy... a licensed 503A compounding pharmacy" — and sells all three tracked compounds from one company.
Names its dispensing pharmacy directly — its own Cancellation & Refund Policy states, "dispensed through Strive Pharmacy... a licensed 503A compounding pharmacy"
Its shop and homepage agree on a real $175/4-week floor for injectable Sermorelin — but its own dedicated /sermorelin/ marketing page advertises a different, lower, and unmatched "$135" figure instead.
A real, live $175/month floor for a 4-Week Supply that its own homepage banner and shop data independently agree on — a genuine standing price, not an intro rate
The only provider here to name a specific pharmacy AND state a regulatory category on the same page — with honest pay-as-you-go pricing, but no state list published anywhere.
Its own How It Works page names Hallandale Pharmacy directly AND states "U.S.-licensed 503A compounding pharmacies" on the same page — the only provider here to clear that bar
Names its pharmacy directly ON its own product page — Rush Pharmacy — and its all-50-states claim carries no caveat. Fridays also names actual pharmacies (four of them, in its own Terms & Conditions), but not on the product page itself the way Precision Telemed does. (Empower Pharmacy also states, in its own words, that it is "a 503A compounding pharmacy" — but it IS the pharmacy, not a reseller naming one — and it publishes no price at all.)
Names its pharmacy (Rush Pharmacy) directly on its own product page and states its regulatory facility category — the only TELEHEALTH provider here that names a pharmacy on the product page itself
Its own tirzepatide and semaglutide pages honestly disclose a first-month promo distinct from the true standing rate — sermorelin doesn't get that same treatment: the site's own homepage price doesn't match the number on its own dedicated sermorelin page at all.
States, directly on its sermorelin page, that "your price stays the same regardless of the dose your clinician prescribes" — a real, flat-pricing commitment most peers here don't make
Names a specific pharmacy AND its category in the same sentence, directly on the sermorelin product page: "Precision Compounding Pharmacy (2640 Merrick Road, Bellmore, NY 11710), a state-licensed 503A compounding pharmacy"
The one provider here that discloses its 1-month, 3-month, and 6-month sermorelin prices together on the same page — but its marketed "180-day money-back guarantee" is far narrower than it sounds once its own Refund Policy is read in full.
$199/mo
What this price covers
✓
Medication
Included
✓
Provider visits
Included
✓
Shipping
Included
–
Lab work
Not disclosed
–
Coaching
Not disclosed
Publishes its 1-month, 3-month, and 6-month prices together on one page — no hidden promo-vs-standing gap to decode
A flat, unpromoted $249/mo for Sermorelin — but the word "compounded" never appears on that specific page, and the same site whose FAQ calls its GLP-1s "FDA-approved" also ships a live Terms of Service with an unfilled "State of [STATE]" governing-law clause.
A genuinely clean, dose-tiered price ladder with no capture-error shape — price rises with dose as clinically expected, not hidden behind a prepay or subscription trap
A flat, unambiguous $116/month — but the outsourcing-facility category claim it makes elsewhere on the site is never repeated on this specific product's own page.
Names four pharmacy partners directly and a clean, unhedged all-50-states claim — the same trust profile as its GLP-1 rows, without the price-contradiction its tirzepatide listing carries.
Its own Terms of Service name FOUR pharmacy partners directly by name — "BPI Labs, Inc.," "VitalRx Pharmacy," "The Pharmacy Hub," and "Olympia Pharmaceuticals" — more specific than most peers here
Names four fulfillment pharmacies directly with city/state, and its LegitScript badge genuinely resolves — but its own tirzepatide-page FAQ states a different regulatory category for a different product than the one its homepage claims, and sermorelin is billed "per 4 weeks," not per calendar month.
Names four fulfillment pharmacies directly by name and city/state on its own homepage (RedRock Pharmacy, Health Warehouse, Precision Medicine, Triad Rx) — more specific than most peers here
States a true no-commitment monthly price directly beside its prepay tiers on the same page for all three compounds — but names no pharmacy at all, and carries no accreditation badge to independently check.
States the true no-commitment month-to-month price directly beside each prepay tier on the same page — the FAQ states plainly, "Start monthly with no commitment — switch to a longer plan anytime after your consult"
A flat, unhedged $189/month with no prepay tier to decode — but its own Refund Policy discloses that a "monthly" subscription actually bills every 3 weeks, not every calendar month.
A 3-month prepay that is genuinely cheaper rather than a trap — $474 against $597 for three separate monthly charges — with providers licensed in all 50 states.
Its own sermorelin page carries the same "not reviewed or approved by the FDA" disclaimer as its other products — unlike Ivim Health's sermorelin listing here — but its own FAQ still describes VIV RX's plan using a different company's name.
Unlike Ivim Health's sermorelin listing here, VIV RX's sermorelin page carries the same "not reviewed or approved by the FDA" disclaimer its tirzepatide and semaglutide pages do — a product-specific gap Ivim's sermorelin page has and VIV RX's doesn't
Its own sermorelin page and its own checkout funnel agree on the true $249/mo price — genuinely undisguised, unlike its own tirzepatide listing — but the same LegitScript badge that fails to resolve there is embedded on this page too.
Its own sermorelin page and its own checkout funnel headline agree on the same $249/mo standing price — genuinely undisguised, a cleaner story than several peers here and than BluefitMD's own tirzepatide listing
Names four partner pharmacies by name (a fifth in its Help Center) and states, in its own words, that "All partner pharmacies are 503A-accredited" — tied with EOS Health for the most named pharmacies of any telehealth reseller here — at a plain, single price with no promo code found for this product.
Names four partner pharmacies by name and address in its own Terms & Conditions, plus a fifth in its Help Center, which states, in its own words, that "All partner pharmacies are 503A-accredited" — tied with EOS Health for the most named pharmacies of any telehealth reseller here
Its own sermorelin page carries the same "not FDA-approved" disclaimer as its other products, and a flat, no-dose-tier price — but its own FAQ names one "exclusive" fulfillment pharmacy while its own Returns Policy ships prescriptions from a second, different one.
States plainly, "Compounded medications are not FDA-approved," directly on the sermorelin page itself — the same disclosure several peers here only carry elsewhere on the site or not at all
The most directly self-identified compounding pharmacy here — Empower names its own regulatory categories in its own words ("a 503A compounding pharmacy and 503B outsourcing facility"), sitewide, rather than describing a partner
"$199/mo" reads like a standing price — the same page's own footnote requires a 3-month prepay to get it, and the true one-time "Regular price" is $295.
Its own sermorelin page states the required $75/mo membership directly beside the medication price — a more honest disclosure than its own tirzepatide listing — but the same prepaid multi-month "Program" structure and mid-term-cancellation lock-in apply either way.
States the $75/mo membership directly beside the $129 medication price on the sermorelin page itself — more transparent than several peers here, and than Ivim's own tirzepatide listing
A coupon is silently auto-applied to every visitor's price by default — the true standing rate, confirmed directly against ReadyRx's own live pricing API, is $225/month.
The true standing, no-commitment monthly price is independently confirmable by querying ReadyRx's own live pricing API directly, not just reading marketing copy
A real $33M Series A and an independently-corroborated legal entity behind it — but its own sermorelin page's "$130/mo + membership" doesn't say which membership, and its own site markup tags the product Premium Tier, the $155/month plan: a $285/month true cost, more than double the headline.
A genuinely strong, independently-verifiable legitimacy signal most peers here lack: a real $33M Series A reported by WWD and MedCity News, not just a self-published claim
What determines a row's position is printed below, and nothing else moves it: a commercial relationship can earn a provider a disclosed, labeled placement, but it cannot change the criteria, the verified prices, or the drawbacks we print beside any row. The 4 factors below are what actually move a row up or down.
Pharmacy sourcing, on the record or not
We only mark a provider's pharmacy chip with a regulatory facility category when its own site names the facility AND states that category — of the 75 providers here, 21 do. Everyone else is marked "Not disclosed," which is a real finding about the provider, not a gap in our research.
A floor isn't a price
Two of the three providers here quote a "starting at" number with no published ceiling. The exception states both a first-month price and the ongoing recurring rate plainly, and its own FAQ commits to no lock-in — a checkable claim, not one we had to infer.
How the order is set
Any paid placement is marked Partner and listed first, as a disclosed commercial position — see the disclosure below the board. Within that group, and separately within every other row, the same rule applies: sorted by whether the provider clears the pharmacy-disclosure bar above, then by their own advertised price, low to high, for rows that tie. A provider's placement within its own group is never for sale.
One row we couldn't fully check ourselves
PlexusDx's own product pages would not load for us on any attempt on August 2026, so its pricing comes from its homepage and its state-coverage claim comes from a search engine's snapshot of its own blog post — not a page we opened ourselves. Its entry says so plainly.
Before you compare prices: sermorelin sold here is compounded, made by a pharmacy under FDA compounding rules rather than as an FDA-approved drug product. There is no clinical-trial evidence that sermorelin improves athletic performance or body composition, and growth hormone and its secretagogues are prohibited in tested sport at all times — see the anti-doping note below. What we score here is how honestly and clearly each provider states its price and sourcing, for people who have already decided to pursue a legally prescribed program — not a claim about whether sermorelin works. Talk to a licensed clinician about that part.
Only sermorelin sellers are ranked here. Shopping for a GLP-1 instead? Our tirzepatide comparison and our semaglutide comparison both use the same pharmacy-first method against larger, different rosters (both include yourEra, which doesn't sell sermorelin) — sermorelin has no FDA-approved retail equivalent and a very different WADA status of its own (banned at all times, not monitored like the two GLP-1s).
Nothing on this page is medical advice. Compounded sermorelin requires a clinician's prescription and is not an FDA-approved product. Sermorelin belongs to WADA's S2 category (growth hormone and the peptides that trigger its release), which stays on the Prohibited List year-round for anyone drug-tested — a valid prescription doesn't create an exception. We read every price and sourcing claim on this page directly off each provider's own site in August 2026; providers change prices without telling us, so verify the current number before you buy. Ask a licensed clinician whether a peptide program of any kind fits your situation.